FMED 股價展望與 ETF 分析 - 配息·管理費·持股·NAV·RSI·MACD

FMED

Fidelity Disruptive Medicine ETF

收盤價 10月23日 4:00 PM ET（韓國 10/24 05:00）

$31.54

-0.08 ▼ -0.25%

10月23日 4:00 PM ET（韓國 10/24 05:00）

$31.54

+0.00 +0.00%

上升三角形阻力線 32.62 支撐線 30.51 維持連續3天同一條線由 AI 繪製的參考線，可能有誤，僅供參考，並非預測。

詳細指標表

Category ⓘ	US Equities - Industry Sector	Expense ⓘ	0.5%	Return% 1Y ⓘ	19.26%	Total Holdings ⓘ	76	Perf Week ⓘ	4.12%	Volume ⓘ	10,817
Asset Type ⓘ	Equities (Stocks)	AUM ⓘ	$51M	Return% 3Y ⓘ	13.67%	NAV ⓘ	$31.68	Perf Month ⓘ	-2.16%	Avg Volume ⓘ	0.01M
ETF Type ⓘ	US Equities	Dividend TTM ⓘ	-	Return% 5Y ⓘ	-	52W High ⓘ	-4.38%	Perf Quarter ⓘ	11.16%	Rel Volume ⓘ	1.49
Active/Passive ⓘ	Active	Div Gr. 3/5Y ⓘ	-	Return% 10Y ⓘ	-	52W Low ⓘ	34.32%	Perf Half Y ⓘ	25.55%	Prev Close ⓘ	$31.62
IPO ⓘ	2023/6/12	Flows% 1M ⓘ	0%	Return% SI ⓘ	7.02%	RSI (14) ⓘ	51.28	Perf YTD ⓘ	16.6%	Price ⓘ	$31.54
Beta ⓘ	0.78	Flows% 3M ⓘ	0%	Flows% YTD ⓘ	-25.03%	Flows% 1Y ⓘ	-21.86%	Perf Year ⓘ	19.26%	Volatility(W/M) ⓘ	2.05% 1.99%
SMA20 ⓘ	0.27%	SMA50 ⓘ	-0.29%	SMA200 ⓘ	14.05%	ATR ⓘ	0.69

ETF 簡介

Fidelity Disruptive Medicine ETFFMED | NASD | 主動管理型查看深度分析

Fidelity Disruptive Medicine ETF seeks long-term growth of capital. The fund normally invests at least 80% of assets in securities of disruptive medicine companies. Fidelity's disruptive strategies seek to identify innovative developments that could signal new directions for delivering products and services to customers. Generally, these companies have or are developing new or unconventional ways of doing business that could disrupt and displace incumbents over time. The fund is non-diversified.

FMED ETF 一覽

0.5% 越低越好

$51M 管理資產

76檔

掛牌日 2023年

管理方式主動管理

發行公司 Fidelity

主要持有標的持有 76 檔

前 10 大持股占 基金的 40%